San Diego, CA -- (SBWIRE) -- 02/04/2021 -- An investor, who purchased shares of Decision Diagnostics Corp. (OTC: DECN), filed a lawsuit over alleged violations of Federal Securities Laws by Decision Diagnostics Corp.

Investors who purchased shares of Decision Diagnostics Corp. (OTC: DECN) have certain options and for certain investors are short and strict deadlines running. Deadline: March 16, 2021. OTC: DECN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Westlake Village, CA based Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. Decision Diagnostics Corp claimed early in the year that it had a finger prick test that could detect the novel coronavirus and return results in less than one minute.

On December 17, 2020, the U.S. Securities and Exchange Commission ("SEC") filed a lawsuit alleging Decision's claims were untrue.

Shares of Decision Diagnostics Corp. (OTC: DECN) declined from $0.45 per share in August 2020 to as low as $0.01 per share on December 21, 2020.

The plaintiff claims that between March 3, 2020 and December 17, 2020, the Defendants made false and/or misleading statements and failed to disclose to investors that Decision Diagnostics had not developed any viable COVID-19 test, much less a test that could detect COVID-19 in less than one minute, that the Company could not meet the FDA's EUA testing requirements for its purported COVID-19 test, that accordingly, Defendants had misrepresented the timeline within which it could realistically bring its COVID-19 test to market; (iv) all the foregoing subjected Defendants to an increased risk of regulatory oversight and enforcement, and that as a result, Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of Decision Diagnostics Corp. (OTC: DECN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.